Meeting highlights from: 47th Annual Meeting of the American Society of Hematology December 2005, Atlanta, GA.  [electronic resource] 

 -  Clinical lymphoma & myeloma  May 2006 
 - 448-54 p.  digital 
<br/><br/> Publication Type: Congress 
<br/><br/><label>ISSN: </label>1557-9190 
<br/><br/><label>Standard No.: </label>10.1016/s1557-9190(11)70290-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Clinical Trials as Topic<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Hematology--trends<br/>Humans<br/>Hydroxamic Acids--toxicity<br/>Indoles<br/>Lymphoma--drug therapy<br/>Panobinostat<br/>Prednisone--administration & dosage<br/>Rituximab<br/>Vincristine--administration & dosage